Josh Baltzell

Venture Partner - Split Rock Partners, SightLine Partners

Josh is a Venture Partner at Split Rock Partners, and also serves as a Venture Partner at SightLine Partners. He has been with Split Rock since 2004 and with SightLine since 2014. Mr. Baltzell has over 20 years of experience in the healthcare industry.

Prior to his tenure in the venture capital industry, Josh held roles as an investment banker at Piper Jaffray Companies from 2000 to 2002, where he focused primarily on mergers and acquisitions in the medical device sector as well as various marketing and business development positions with SCIMED and Boston Scientific. Josh currently serves on the boards of Colorescience, EBR Systems, Inc., Entellus Medical (NASDAQ: ENTL), Histogenics Corporation (NASDAQ: HSGX) and Nanocyte Medical. Josh is also a co-inventor of the DentaDish.

Josh’s previous investments and board affiliations have resulted in several M&A transactions including Ardian (Medtronic), Dfine (Merit Medical), RF Surgical (Medtronic), Skinmedica (Allergan) and Tarsus (Integra Lifesciences).

Josh holds a B.A. in Economics from St. Olaf College and an M.B.A. from the University of Minnesota’s Carlson School of Management.